United States · Series B startup
One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 3 months ago
Follow Khartis Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 5 Nov 2026
$50Mraised across 1 round since 2026, from 1 source
Missing a round, or an investor who was in one? Tell us.
Khartis Therapeutics's investors include Forge Life Science Partners, Alexandria Venture Investments, Foresite Capital, Lilly Asia Ventures and Longwood Fund, and 1 more on record. Forge Life Science Partners led its latest round.
Khartis Therapeutics has raised $50M across 1 round since 2026.
Khartis Therapeutics's most recent round was a Series B of $50M in Aug 2026, led by Forge Life Science Partners.
Its most recent round, $50M in Aug 2026, is also its largest on record.
Khartis Therapeutics's first round on record, in Aug 2026, was backed by Forge Life Science Partners, Alexandria Venture Investments and Foresite Capital and 3 others.
Khartis Therapeutics's latest named round is a Series B, in Aug 2026.
Khartis Therapeutics is based in the United States.
Forge Life Science Partners led the Series B in 2026.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
